France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
France
France / Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for their work on COVID-19 vaccines, smaller and lesser-known companies are also playing…
M&A / Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty Pivot
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
News Roundup / French Pharma August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
In Conversation
Frédéric Cren – Chairman, CEO & Co-Founder, Inventiva, France
Inventiva is a French clinical-stage biotech company focused on developing oral small molecule epigenetic modulators in therapeutic areas with high unmet medical needs such as fibrosis, lysosomal storage disorders and oncology. Its most advanced program is a first-in-class drug candidate against NASH. Inventiva’s chairman, CEO and co-founder, Frédéric Cren, explains how the company leverages its unique assets to deliver its…
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
Related Report
Stéphane Péden – General Manager, Chamber of Commerce and Industry…
Stéphane Péden, general manager of the Chamber of Commerce & Industry France Taiwan (CCIFT), describes how…
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a…
‘La French Tech’: France’s new entrepreneurial vibe
Growing awareness of start-up activity within France, fuelled by Minister for the Economy, Industry and Digital…
NEW France Pharma Report Out Now!
France is rediscovering its mojo. After a period of relative stagnation, the country’s highly strategic USD 65…
France: A World Leader in Oncology
Due to high unmet medical need, oncology is set to remain as the number one therapeutic area globally in the coming…
Brexit: A Window of Opportunity for France’s Drug Regulator?
As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…
AI / France's Quest for Life Sciences 4.0
With Minister of the Economy and Finance, Bruno Le Maire, emphasizing the importance of “winning the battle on…
France / Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic Cases; Ipsen Growth
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
Internationalization / France's Mid-Cap Pharma Champions Look to Global Markets
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma…
Sanofi / Thomas Triomphe Appointed Executive Vice President of Vaccines Unit
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
France / Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
M&A / Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty Pivot
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
Top Causes of Death in France
Cancer is the leading cause of death in France, accounting for 28.5% of all deaths in 2014, followed by…
Ipsen / New CEO as David Loew Makes Switch From Sanofi Pasteur
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
AMR / France: Becoming a European Vaccination Leader?
France is home to the highest rates of vaccine mistrust in Europe, with a third of French people disagreeing that…